Briefing
Circulating Tumor DNA Analysis Guiding Adjuvant Therapy in Stage II Colon Cancer.
A randomized trial tested whether a ctDNA-guided approach could reduce adjuvant chemotherapy in stage II colon cancer without increasing recurrence. The abstract does not name the assay.
- Design: Evidence level 1
- Assay: Not named in the abstract
The New England Journal of MedicinePubMed 35657320DOI 10.1056/NEJMoa2200075